Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Litchfield, Lacey M ^a   Riggs, Krista A ^a   Hockenberry, Alyson M ^a   Oliver, Laura D ^a   Barnhart, Katelyn G ^a   Cai, Jian ^b   Pierce, William M ^b   Ivanova, Margarita M ^a   Bates, Paula J ^c   Appana, Savitri N ^d   Datta, Susmita ^d   Kulesza, Piotr ^e   McBryan, Jean ^f   Young, Leonie S ^f   Klinge, Carolyn M ^a  

^a Center for Genetics and Molecular Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GELATINASE A; NUCLEAR RECEPTOR COUP TFII; NUCLEAR RECEPTOR NR2F2; NUCLEOLIN; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA 2; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TAMOXIFEN; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG; AGRO 100; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOPROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RNA BINDING PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; TRANSCRIPTION REGULATION; ANIMAL; BREAST TUMOR; CELL NUCLEUS; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; NUCLEOTIDE REPEAT; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ATRA;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; COUP TRANSCRIPTION FACTOR II; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM GRADING; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, RETINOIC ACID; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; TRANSCRIPTIONAL ACTIVATION; TRETINOIN;

EID: 84861709460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038278     Document Type: Article

References (72)

1. Tsai SY, Tsai M-J, (1997) Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): Coming of age. Endocrine Rev 18: 229-240.
2. Qiu Y, Pereira FA, DeMayo FJ, Lydon JP, Tsai SY, et al. (1997) Null mutation of mCOUP-TFI results in defects in morphogenesis of the glossopharyngeal ganglion, axonal projection, and arborization. Genes Dev 11: 1925-1937.
3. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY, (1999) The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 13: 1037-1049.
4. Kruse SW, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, et al. (2008) Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol 6: e227.
5. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The Consensus Coding Sequences of Human Breast and Colorectal Cancers. Science 314: 268-274.
6. Almendro V, Fuster G, (2011) Heterogeneity of breast cancer: etiology and clinical relevance. Clinical and Translational Oncology 13: 767-773.
7. Huang TH-M, Esteller M, (2010) Chromatin Remodeling in Mammary Gland Differentiation and Breast Tumorigenesis. Cold Spring Harbor Perspectives in Biology 2.
8. Russo J, Russo IH, (2006) The role of estrogen in the initiation of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 102: 89-96.
9. Jordan VC, Obiorah I, Fan P, Kim HR, Ariazi E, et al. (2011) The St. Gallen Prize Lecture 2011: Evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities. The Breast 20, Supplement 3: S1-S11.
10. Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, et al. (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. PNAS 98: 15197-15202.
11. Wakeling AE, Bowler J, (1992) ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Mol Biol 43: 173-177.
12. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A, (2009) History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target. Endocr Rev 30: 343-375.
13. Riggs KA, Wickramasinghe NS, Cochrum RK, Watts MB, Klinge CM, (2006) Decreased Chicken Ovalbumin Upstream Promoter Transcription Factor II Expression in Tamoxifen-Resistant Breast Cancer Cells. Cancer Res 66: 10188-10198.
14. Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ Jr, et al. (2000) The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2. Biochem Biophys Res Commun 270: 1144-1153.
15. Nagasaki S, Suzuki T, Miki Y, Akahira JI, Shibata H, et al. (2009) Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Sci 13: 13.
16. Qin J, Chen X, Xie X, Tsai M-J, Tsai SY, (2010) COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proceedings of the National Academy of Sciences 107: 3687-3692.
17. Shibata H, Nawaz Z, Tsia SY, O'Malley BW, Tsai M-J, (1997) Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol Endocrinol 11: 714-724.
18. De Martino MU, Bhattachryya N, Alesci S, Ichijo T, Chrousos GP, et al. (2004) The Glucocorticoid Receptor and the Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor II Interact with and Mutually Affect Each Other's Transcriptional Activities: Implications for Intermediary Metabolism. Mol Endocrinol 18: 820-833.
19. Rohr O, Aunis D, Schaeffer E, (1997) COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in human microglial cells. J Biol Chem 272: 31149-31155.
20. Rohr O, Schwartz C, Hery C, Aunis D, Tardieu M, et al. (2000) The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cells. J Biol Chem 275: 2654-2660.
21. Senawong T, Peterson VJ, Avram D, Shepherd DM, Frye RA, et al. (2003) Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem 278: 43041-43050.
22. Klinge CM, (1999) Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). J Steroid Biochem Molec Biol 71: 1-19.
23. Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA, et al. (1997) COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression. J Biol Chem 272: 31465-31474.
24. Klinge CM, Kaur K, Swanson HI, (2000) The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRα1. Arch Biochem Biophys 373: 163-174.
25. Shibata H, Kobayashi S, Kurihara I, Suda N, Yokota K, et al. (2004) COUP-TF and transcriptional co-regulators in adrenal steroidogenesis. Endocr Res 30: 795-801.
26. Zhang L-j, Liu X, Gafken PR, Kioussi C, Leid M, (2009) A Chicken Ovalbumin Upstream Promoter Transcription Factor I (COUP-TFI) Complex Represses Expression of the Gene Encoding Tumor Necrosis Factor {alpha}-induced Protein 8 (TNFAIP8). J Biol Chem 284: 6156-6168.
27. Marcus SL, Winrow CJ, Capone JP, Rachubinski RA, (1996) A p56lck ligand serves as a coactivator of an orphan nuclear hormone receptor. J Biol Chem 271: 27197-27200.
28. De Martino MU, Alesci S, Chrousos GP, Kino T, (2004) Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism. Ann N Y Acad Sci 1024: 72-85.
29. Keen JC, Davidson NE, (2003) The biology of breast carcinoma. Cancer 97: 825-833.
30. Yang Q, Sakurai T, Kakudo K, (2002) Retinoid, retinoic acid receptor beta and breast cancer. Breast Cancer Res Treat 76: 167-173.
31. Lin B, Chen GQ, Xiao D, Kolluri SK, Cao X, et al. (2000) Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 20: 957-970.
32. Girvan AC, Teng Y, Casson LK, Thomas SD, Juliger S, et al. (2006) AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin. Mol Cancer Ther 5: 1790-1799.
33. Hanakahi LA, Bu Z, Maizels N, (2000) The C-Terminal Domain of Nucleolin Accelerates Nucleic Acid Annealing†. Biochemistry 39: 15493-15499.
34. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, et al. (2009) Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence. Clin Cancer Res 15: 2098-2106.
35. Qin L, Liao L, Redmond A, Young L, Yuan Y, et al. (2008) The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression. Mol Cell Biol 28: 5937-5950.
36. Greene FL, Sobin LH, (2008) The Staging of Cancer: A Retrospective and Prospective Appraisal. CA: A Cancer Journal for Clinicians 58: 180-190.
37. Qiu Y, Krishnan V, Zeng Z, Gilbert DJ, Copeland NG, et al. (1995) Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes. Genomics 29: 240-246.
38. Teng Y, Girvan AC, Casson LK, Pierce WM Jr, Qian M, et al. (2007) AS1411 Alters the Localization of a Complex Containing Protein Arginine Methyltransferase 5 and Nucleolin. Cancer Res 67: 10491-10500.
39. Desai D, Michalak M, Singh NK, Niles RM, (1996) Inhibition of Retinoic Acid Receptor Function and Retinoic Acid-regulated Gene Expression in Mouse Melanoma Cells by Calreticulin. Journal of Biological Chemistry 271: 15153-15159.
40. Liang ZD, Lippman SM, Wu T-T, Lotan R, Xu X-C, (2006) RRIG1 Mediates Effects of Retinoic Acid Receptor β2 on Tumor Cell Growth and Gene Expression through Binding to and Inhibition of RhoA. Cancer Research 66: 7111-7118.
41. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, et al. (2008) Estradiol stimulates transcription of Nuclear Respiratory Factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 22: 609-622.
42. Reyes-Reyes EM, Teng Y, Bates PJ, (2010) A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism. Cancer Research 70: 8617-8629.
43. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO, (2009) Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Experimental and Molecular Pathology 86: 151-164.
44. Mongelard F, Bouvet P, (2007) Nucleolin: a multiFACeTed protein. Trends in Cell Biology 17: 80-86.
45. Tediose T, Kolev M, Sivasankar B, Brennan P, Morgan BP, et al. (2010) Interplay between REST and nucleolin transcription factors: a key mechanism in the overexpression of genes upon increased phosphorylation. Nucleic Acids Research 38: 2799-2812.
46. Ying G-G, Proost P, van Damme J, Bruschi M, Introna M, et al. (2000) Nucleolin, a Novel Partner for the Myb Transcription Factor Family That Regulates Their Activity. J Biol Chem 275: 4152-4158.
47. Tsou J-H, Chang K-Y, Wang W-C, Tseng JT, Su W-C, et al. (2008) Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2{alpha} in phorbol ester-treated non-small cell lung cancer A549 cells. Nucl Acids Res 36: 217-227.
48. Uribe DJ, Guo K, Shin Y-J, Sun D, (2011) Heterogeneous Nuclear Ribonucleoprotein K and Nucleolin as Transcriptional Activators of the Vascular Endothelial Growth Factor Promoter through Interaction with Secondary DNA Structures. Biochemistry 50: 3796-3806.
49. Berns EM, van Staveren IL, Klijn JG, Foekens JA, (1998) Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer. Breast Cancer Res Treat 48: 87-92.
50. McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, et al. (2012) Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1. Cancer Research 72: 548-559.
51. Petit FG, Salas R, Tsai M-J, Tsai SY, (2004) The regulation of COUP-TFII gene expression by Ets-1 is enhanced by the steroid receptor co-activators. Mechanisms of Ageing and Development 125: 719-732.
52. More E, Fellner T, Doppelmayr H, Hauser-Kronberger C, Dandachi N, et al. (2003) Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines. J Endocrinol 176: 83-94.
53. Lin F, Kolluri SK, Chen GQ, Zhang XK, (2002) Regulation of Retinoic Acid-induced Inhibition of AP-1 Activity by Orphan Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor. J Biol Chem 277: 21414-21422.
54. Xie X, Qin J, Lin S-H, Tsai SY, Tsai M-J, (2011) Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proceedings of the National Academy of Sciences 108: 14843-14848.
55. Bates PJ, Kahlon JB, Thomas SD, Trent JO, Miller DM, (1999) Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding. J Biol Chem 274: 26369-26377.
56. Rousseau C, Pettersson F, Couture MC, Paquin A, Galipeau J, et al. (2003) The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. J Steroid Biochem Mol Biol 86: 1-14.
57. Xu X-C, (2007) Tumor-suppressive activity of retinoic acid receptor-[beta] in cancer. Cancer Letters 253: 14-24.
58. Masiuk M, Urasinska E, Domagala W, (2004) Simultaneous measurement of nucleolin and estrogen receptor in breast cancer cells by laser scanning cytometry. Anticancer Res 24: 963-966.
59. Storck S, Shukla M, Dimitrov S, Bouvet P, (2007) Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 41: 125-144.
60. Navab R, Gonzalez-Santos JM, Johnston MR, Liu J, Brodt P, et al. (2004) Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells. Cancer Res 64: 5097-5105.
61. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
62. Conzen SD, (2008) Minireview: Nuclear Receptors and Breast Cancer. Mol Endocrinol 22: 2215-2228.
63. Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, et al. (2003) Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem 278: 8572-8579.
64. Kraus WL, (2008) Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Current Opinion in Cell Biology 20: 294-302.
65. Ju B-G, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, et al. (2006) A Topoisomerase II{beta}-Mediated dsDNA Break Required for Regulated Transcription. Science 312: 1798-1802.
66. Malanga M, Czubaty A, Girstun A, Staron K, Althaus FR, (2008) Poly(ADP-ribose) Binds to the Splicing Factor ASF/SF2 and Regulates Its Phosphorylation by DNA Topoisomerase I. J Biol Chem 283: 19991-19998.
67. Gonzalez V, Guo K, Hurley L, Sun D, (2009) Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein. Journal of Biological Chemistry 284: 23622-23635.
68. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ, (2008) The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells. Cancer Res 68: 2358-2365.
69. Ishimaru D, Zuraw L, Ramalingam S, Sengupta TK, Bandyopadhyay S, et al. (2010) Mechanism of Regulation of bcl-2 mRNA by Nucleolin and A+U-rich Element-binding Factor 1 (AUF1). Journal of Biological Chemistry 285: 27182-27191.
70. Theodosiou M, Laudet V, Schubert M, (2010) From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci.
71. Faria TN, Mendelsohn C, Chambon P, Gudas LJ, (1999) The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274: 26783-26788.
72. Tamimi RM, Colditz GA, Hankinson SE, (2009) Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer. Cancer Res 69: 9323-9329.